These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25650810)

  • 1. Albumin dialysis in artificial liver support systems: open-loop or closed-loop dialysis mode?
    Pei Y; Sun Y; Sun S; Gao D; Ding W
    ASAIO J; 2015; 61(3):324-31. PubMed ID: 25650810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A pilot study of using pure albumin as a dialysate in the treatment of liver failure].
    Liu Q; Peng L; Du Y; Li M; Jia N; Zou HQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):599-602. PubMed ID: 16259917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Pass Albumin Dialysis-A Dose-Finding Study to Define Optimal Albumin Concentration and Dialysate Flow.
    Schmuck RB; Nawrot GH; Fikatas P; Reutzel-Selke A; Pratschke J; Sauer IM
    Artif Organs; 2017 Feb; 41(2):153-161. PubMed ID: 27121702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
    Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
    Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles of bound solute dialysis.
    Patzer J
    Ther Apher Dial; 2006 Apr; 10(2):118-24. PubMed ID: 16684212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow continuous ultrafiltration with bound solute dialysis.
    Patzer JF; Safta SA; Miller RH
    ASAIO J; 2006; 52(1):47-58. PubMed ID: 16436890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two different modes of molecular adsorbent recycling systems for liver dialysis.
    Soo E; Sanders A; Heckert K; Vinke T; Schaefer F; Schmitt CP
    Pediatr Nephrol; 2016 Nov; 31(11):2171-4. PubMed ID: 27394132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.
    Wittebole X; Hantson P
    Clin Toxicol (Phila); 2011 Nov; 49(9):782-93. PubMed ID: 22077243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging indications for albumin dialysis.
    Sen S; Williams R; Jalan R
    Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver support systems today].
    Rikker C
    Orv Hetil; 2009 Dec; 150(51):2299-307. PubMed ID: 19995693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24-hour performance of albumin dialysis assessed by a new two-compartment in vitro model.
    Stiffel M; Dammeier N; Schmidt S; Szyszkowitz T; Sikole M; Sieveking C; Stange J
    Ther Apher Dial; 2014 Feb; 18(1):79-86. PubMed ID: 24499088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearing of toxic substances: are there differences between the available liver support devices?
    Krisper P; Stadlbauer V; Stauber RE
    Liver Int; 2011 Sep; 31 Suppl 3():5-8. PubMed ID: 21824275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of therapeutic albumin solutions used for molecular adsorbent recirculating system-based liver dialysis.
    De Bruyn T; Meijers B; Evenepoel P; Laub R; Willems L; Augustijns P; Annaert P
    Artif Organs; 2012 Jan; 36(1):29-41. PubMed ID: 21955219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin dialysis: single pass vs. recirculation (MARS).
    Peszynski P; Klammt S; Peters E; Mitzner S; Stange J; Schmidt R
    Liver; 2002; 22 Suppl 2():40-2. PubMed ID: 12220302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin regeneration in liver support-comparison of different methods.
    Mitzner S; Klammt S; Stange J; Schmidt R
    Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method to increase the adsorption of protein-bound toxins in artificial liver support systems.
    Ding W; Zou L; Sun S; Li W; Gao D
    Artif Organs; 2014 Nov; 38(11):954-62. PubMed ID: 24660863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia in nondiabetic patients undergoing albumin dialysis by molecular adsorbent recirculating system.
    Khoo AL; Tham LS; Lim GK; Lee KH
    Liver Transpl; 2003 Sep; 9(9):949-53. PubMed ID: 12942456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
    Evenepoel P; Laleman W; Wilmer A; Claes K; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
    Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective bilirubin reduction by single-pass albumin dialysis in liver failure.
    Boonsrirat U; Tiranathanagul K; Srisawat N; Susantitaphong P; Komolmit P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Artif Organs; 2009 Aug; 33(8):648-53. PubMed ID: 19624591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver failure: basis of benefit of therapy with the molecular adsorbents recirculating system.
    Sen S; Jalan R; Williams R
    Int J Biochem Cell Biol; 2003 Sep; 35(9):1306-11. PubMed ID: 12798344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.